The National Children's Study: an opportunity for medical toxicology

Mary Ellen Mortensen1, Steven Hirschfeld

  • 1Division of Laboratory Sciences, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA. zeo4@cdc.gov

Insights

The National Children's Study (NCS) investigates how biological, environmental, genetic, and social factors impact child health. This large-scale, longitudinal study uses a data-driven approach with pilot testing to inform its design and future research.

Area of Science:

  • Environmental Health
  • Pediatric Health
  • Longitudinal Studies

Background:

  • The National Children's Study (NCS) is a Congressionally mandated longitudinal study to examine environmental, genetic, and social influences on US children's health.
  • The study is implemented by the National Institutes of Health (NIH) with interagency collaboration, including the Centers for Disease Control and Prevention (CDC) and Environmental Protection Agency (EPA).

Purpose of the Study:

  • To prospectively investigate the multifaceted factors affecting child health and development.
  • To establish evidence-based methodologies and protocols for a large-scale national study.
  • To explore collaborative opportunities for enhancing study design and research capabilities.

Main Methods:

  • The NCS employs an integrated system with multiple data acquisition strategies, including the Vanguard Study (pilot), Main Study, and sub-studies.
  • The Vanguard Study, a pilot phase, is expanding to 37 locations, field-testing protocols and recruitment strategies.
  • Collaborative pilot studies, such as one with the CDC, evaluate biological specimen protocols and environmental/nutritional exposures.

Main Results:

  • The Vanguard Study is currently underway, field-testing and refining study protocols and recruitment strategies.
  • Pilot collaborations are providing valuable data on environmental chemical exposures and nutritional indicators.
  • Revisions to study protocols and recruitment strategies are under consideration based on field testing.

Conclusions:

  • The NCS utilizes a phased approach, including pilot studies like the Vanguard Study, to ensure a robust and evidence-based design.
  • Collaboration, particularly with experts like medical toxicologists, is crucial for enhancing the NCS design and future research.
  • The study's comprehensive approach aims to provide critical insights into the determinants of child health and development.

Related Concept Videos

Toxicity Testing in Animals01:23

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
Types of Toxins01:36

Types of Toxins

Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Toxicokinetics: Overview01:21

Toxicokinetics: Overview

Studies that assess how a drug is absorbed, distributed, metabolized, and excreted (ADME) at toxic doses are termed toxicokinetics. Understanding toxicokinetics helps predict adverse drug reactions (ADRs) and manage toxicity in humans.Toxicokinetics differs from pharmacokinetics mainly in the dose levels studied, with toxicokinetics focusing on higher toxic doses. The kinetics at these levels can be non-linear due to altered physiological processes. Toxicodynamics examines the relationship...
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
Toxic Reactions: Overview01:26

Toxic Reactions: Overview

When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...